The Accad and Koka Report

Home | Mises Library | 47. Drug Dosing: One Size Does Not Fit All

47. Drug Dosing: One Size Does Not Fit All

  • The Accad & Koka Report

Tags Health

11/30/2018Michel AccadAnish Koka

Patients come in all sizes and shapes, and with varying tolerance for complications and risk. Is it plausible that a single dosing regimen can optimize treatment for everybody? If not, what is keeping the pharmaceutical industry from endorsing a more dynamic and patient-centered drug dosing regimen?

Our guest is Dr. David Norris, a physician, mathematician, and inventor. David operates a scientific and statistical consultancy focused on methodology development for ‎precision-medicine applications. He developed Dose Titration Algorithm Tuning (DTAT), a methodological framework that conceives dose individualization as a seamless learning process, beginning in early-phase trials and continuing throughout the drug development process. Before earning his M.D. at Brown University, he worked in diverse application areas including mathematical finance, operations research and systems engineering.

The Accad and Koka Report podcast, hosted by two MDs, focuses on free-market approaches to medicine and health. Subscribe on iTunes, Android, Stitcher, or via RSS.

Note: The views expressed on are not necessarily those of the Mises Institute.
When commenting, please post a concise, civil, and informative comment. Full comment policy here
Shield icon interview